The Journal of antimicrobial chemotherapy · 2026
Harnessing metabolic dependence-driven antibiotic synergy to eradicate tolerant Pseudomonas aeruginosa.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ji Yuanye, Tuo Ping, Ruan Chunyan, Zhang Sijia, Wang Fajiu, Shen Jia, Zhu Peng
Аннотация
BACKGROUND: Pseudomonas aeruginosa is a major nosocomial pathogen, and its antibiotic tolerance under low-metabolism conditions severely compromises clinical efficacy, presenting a significant therapeutic challenge.
OBJECTIVES: A quantitative assessment of the metabolic dependence of clinically relevant antibiotics against P. aeruginosa was conducted, and a novel combination strategy capable of eradicating its low-metabolic populations was developed.
METHODS: We established a gradient nutrient model (0%-100% LB) to simulate a continuum of metabolic states. Through linear regression analysis correlating ATP levels with bactericidal efficiency, we developed a Metabolic Dependence Index classification system. Leveraging this system, we designed a Strongly Metabolism-Dependent (SMD) + Weakly Metabolism-Dependent (WMD) synchronous combination strategy, which was subsequently validated using five clinical isolates.
RESULTS: Low-metabolism populations exhibited significantly reduced susceptibility to SMD agents but unaltered tolerance to WMD antibiotics. The SMD + WMD combination achieved enhanced killing of low-metabolism bacteria (>99.999% killing) with a marked dose reduction in vitro. This strategy also improved in vitro clearance efficacy compared to monotherapy. Collectively, our work provides a quantitative framework for targeting metabolic heterogeneity to overcome antibiotic tolerance.
OBJECTIVES: A quantitative assessment of the metabolic dependence of clinically relevant antibiotics against P. aeruginosa was conducted, and a novel combination strategy capable of eradicating its low-metabolic populations was developed.
METHODS: We established a gradient nutrient model (0%-100% LB) to simulate a continuum of metabolic states. Through linear regression analysis correlating ATP levels with bactericidal efficiency, we developed a Metabolic Dependence Index classification system. Leveraging this system, we designed a Strongly Metabolism-Dependent (SMD) + Weakly Metabolism-Dependent (WMD) synchronous combination strategy, which was subsequently validated using five clinical isolates.
RESULTS: Low-metabolism populations exhibited significantly reduced susceptibility to SMD agents but unaltered tolerance to WMD antibiotics. The SMD + WMD combination achieved enhanced killing of low-metabolism bacteria (>99.999% killing) with a marked dose reduction in vitro. This strategy also improved in vitro clearance efficacy compared to monotherapy. Collectively, our work provides a quantitative framework for targeting metabolic heterogeneity to overcome antibiotic tolerance.